Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...

Sales growth driven by continued strong performance from Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% cc), Scemblix (+79% cc), Leqvio (+61% cc) and Pluvicto (+30% cc) Core operating income ...

Analysts on Wall Street project that Thermo Fisher Scientific (TMO) will announce quarterly earnings of $5.22 per share in its forthcoming report, representing a decline of 2.8% year over year.

Thermo Fisher Scientific Inc. TMO is slated to release second-quarter 2025 results on July 23, before market open. Thermo Fisher’s first-quarter earnings of $5.15 per share beat the Zacks Consensus ...

International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...